CRC40088 Pre-harvest for Fruit Fly

CRCNPB funded project aimed to develop improved pre-harvest control strategies for Queensland fruit fly based on autecology and behaviour.

Reproduction of grammar school class portrait including Fred Herz (front center).

Digital Image

Studio portrait of Dr. Moritz Kroner (center) with two unidentified men in military uniform.

Digital Image

Historian Herbert Strauss standing in front of an exhibition at the ZFA (Zentrum für Antisemitismusforschung; Center for Research on Antisemitism); Berlin Portraits Men

Digital Image

Dr. Rainer Erb at the ZFA (Zentrum für Antisemitismusforschung; Center for Research on Antisemitism); Berlin Portraits Men

Digital Image

Ingeborg Medani seated at her desk at the ZFA (Zentrum für Antisemitismusforschung; Center for Research on Antisemitism); Berlin Portraits Women

Digital Image

Two unidentified women working in the Library of the ZFA (Zentrum für Antisemitismusforschung; Center for Research on Antisemitism); Berlin Portraits Women

Digital Image

Exhibition on the history of antisemitism at the ZFA (Zentrum für Antisemitismusforschung; Center for Research on Antisemitism); Berlin.

Digital Image

Telephone and security pad at the entrance of the ZFA (Zentrum für Antisemitismusforschung; Center for Research on Antisemitism); Berlin.

Digital Image

Studies of phosphazenes. 28. Reactions of pentachloro- and pentafluoro(triphenylphosphazenyl)cyclotriphosphazenes with sodium methoxide. Mechanistic aspects and their implications for nucleophilic displacement at a tetrahedral phosphorus(V) center

Abstract is not available.

Young Herbert Strauss (center) with four friends seated on a park bench on the Sabbath; Würzburg.

To the right of Herbert Strauss are Anne Chrenbacher and Walther Reis, to his left are Heinz Ostheim and an unidentified woman

Barley Grains Defects (Blackpoint, Pre-harvest sprouting, Kernal staining)

Screening new and existing breeding germplasm and cultivars for grain defect tolerance for breeding programs, evaluate new methods and technologies to screen more effectively for the barley grains defects - pre-harvest sprouting, blackpoint, kernel discolouration, and investigate genetic mechanisms involved in controlling barley grain defect tolerance.

Pre-emptive Breeding for Russian Wheat Aphid Resistance

The aims of the project are to 1) identify closely linked molecular markers to resistance genes and validate them in Australian wheat and barley backgrounds, and 2) introgress RWA resistance into Australian wheat and barley backgrounds.

Improving oncolytic adenoviral therapies for gastrointestinal cancers and tumor initiating cells

Although the treatment of most cancers has improved steadily, only few metastatic solid tumors can be cured. Despite responses, refractory clones often emerge and the disease becomes refractory to available treatment modalities. Furthermore, resistance factors are shared between different treatment regimens and therefore loss of response typically occurs rapidly, and there is a tendency for cross-resistance between agents. Therefore, new agents with novel mechanisms of action and lacking cross-resistance to currently available approaches are needed. Modified oncolytic adenoviruses, featuring cancer-celective cell lysis and spread, constitute an interesting drug platform towards the goals of tumor specificity and the implementation of potent multimodal treatment regimens. In this work, we demonstrate the applicability of capsid-modified, transcriptionally targeted oncolytic adenoviruses in targeting gastric, pancreatic and breast cancer. A variety of capsid modified adenoviruses were tested for transductional specificity first in gastric and pancreatic cancer cells and patient tissues and then in mice. Then, oncolytic viruses featuring the same capsid modifications were tested to confirm that successful transductional targeting translates into enhanced oncolytic potential. Capsid modified oncolytic viruses also prolonged the survival of tumor bearing orthotopic models of gastric and pancreatic cancer. Taken together, oncolytic adenoviral gene therapy could be a potent drug for gastric and pancreatic cancer, and its specificity, potency and safety can be modulated by means of capsid modification. We also characterized a new intraperitoneal virus delivery method in benefit for the persistence of gene delivery to intraperitoneal gastric and pancreatic cancer tumors. With a silica implant a steady and sustained virus release to the vicinity of the tumor improved the survival of the orthotopic tumor bearing mice. Furthermore, silica gel-based virus delivery lowered the toxicity mediating proimflammatory cytokine response and production of total and anti-adenovirus neutralizing antibodies (NAbs). On the other hand, silica shielded the virus against pre-excisting NAbs, resulting in a more favourable biodistribution in the preimmunized mice. The silica implant might therefore be of interest in treating intraperitoneally disseminated disease. Cancer stem cells are thought to be resistant to conventional cancer drugs and might play an important role in cancer relapse and the formation of metastasis. Therefore, we examined if transcriptionally modified oncolytic adenoviruses are able to kill these cells. Complete eradication of CD44+CD24-/low putative breast cancer stem cells was seen in vitro, and significant antitumor activity was detected in CD44+CD24-/low –derived tumor bearing mice. Thus, genetically engineered oncolytic adenoviruses have potential in destroying cancer initiating cells, which may have relevance for the elimination of cancer stem cells in humans.